The US health authorities cleared Merck’s pill against COVID-19, making it the second anti-viral drug to get approval. Merck said its anti-viral pill ‘Molnupiravir’ reduces around 50% chance of hospitalisation or death for patients at risk of severe disease. Watch to know more.
